泓博医药
(301230)
| 流通市值：59.27亿 | | | 总市值：65.90亿 |
| 流通股本：1.63亿 | | | 总股本：1.81亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 91,612,698.96 | 73,019,064.28 | 59,111,113.54 | 55,315,891.49 |
| 交易性金融资产 | 190,352,876.71 | 215,145,853.36 | 248,976,051.37 | 247,157,476.03 |
| 应收票据及应收账款 | 159,146,194.09 | 139,552,808.04 | 148,431,334.87 | 138,425,951.48 |
| 其中：应收票据 | 7,501,391.17 | 5,373,958.47 | 1,417,352.94 | 1,916,102.5 |
| 应收账款 | 151,644,802.92 | 134,178,849.57 | 147,013,981.93 | 136,509,848.98 |
| 应收款项融资 | 2,257,435.24 | 10,321,710.98 | 2,920,841.36 | 1,027,858.55 |
| 预付款项 | 3,550,661.56 | 4,145,649.07 | 5,040,532.72 | 4,426,100.94 |
| 其他应收款合计 | 4,818,653.4 | 4,723,342.15 | 4,651,686.21 | 4,753,988.86 |
| 存货 | 73,319,374.5 | 90,870,031.28 | 74,046,988.08 | 71,603,894.47 |
| 合同资产 | - | - | 0 | - |
| 其他流动资产 | 40,261,994.43 | 40,355,046.36 | 38,917,357.52 | 40,166,523.68 |
| 流动资产合计 | 565,319,888.89 | 578,133,505.52 | 582,095,905.67 | 562,877,685.5 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 77,444,676.24 | 72,464,025 | 33,170,832 | 33,187,160 |
| 固定资产 | 194,961,380.59 | 193,651,683.31 | 194,548,507.86 | 194,575,350.73 |
| 在建工程 | 7,085,746.72 | 7,406,627.82 | 7,332,859.34 | 6,588,958.05 |
| 使用权资产 | 119,734,662.7 | 130,769,792.55 | 136,496,845.05 | 142,223,897.5 |
| 无形资产 | 9,243,624.12 | 8,500,204.37 | 8,618,862.64 | 8,533,425.25 |
| 长期待摊费用 | 266,818,206.56 | 274,742,379.21 | 283,075,533.83 | 290,239,453.9 |
| 递延所得税资产 | 50,816,246.12 | 48,527,266.48 | 47,195,551.56 | 42,673,610.22 |
| 其他非流动资产 | 11,005,240.6 | 1,647,901.4 | 21,564,277.84 | 24,644,584.21 |
| 非流动资产合计 | 737,109,783.65 | 737,709,880.14 | 732,003,270.12 | 742,666,439.86 |
| 资产总计 | 1,302,429,672.54 | 1,315,843,385.66 | 1,314,099,175.79 | 1,305,544,125.36 |
| 流动负债: | | | | |
| 短期借款 | 5,756,021.53 | 10,010,083.34 | 10,010,083.34 | 18,020,750.24 |
| 应付票据及应付账款 | 52,292,563.18 | 65,877,249.72 | 62,563,735.12 | 47,150,618.9 |
| 应付账款 | 52,292,563.18 | 65,877,249.72 | 62,563,735.12 | 47,150,618.9 |
| 预收款项 | 301.14 | 301.14 | 1,955,750.6 | 2.36 |
| 合同负债 | 8,593,558.85 | 5,761,018.59 | 6,191,549.35 | 7,551,963.74 |
| 应付职工薪酬 | 39,584,172.02 | 34,193,293.97 | 43,738,603.38 | 31,391,865.07 |
| 应交税费 | 984,004.57 | 2,724,162.89 | 2,298,152.01 | 3,299,419.51 |
| 其他应付款合计 | 30,437,482.03 | 5,793,372.4 | 17,927,118.05 | 6,121,968.96 |
| 一年内到期的非流动负债 | 23,197,210.67 | 23,702,238.34 | 25,994,525.19 | 22,638,775.27 |
| 其他流动负债 | 6,954,311.1 | 5,692,795.6 | 1,532,528.63 | 1,832,393.02 |
| 流动负债合计 | 167,799,625.09 | 153,754,515.99 | 172,212,045.67 | 138,007,757.07 |
| 非流动负债: | | | | |
| 租赁负债 | 115,449,652.58 | 125,642,741.88 | 129,304,380.46 | 134,333,677.29 |
| 预计负债 | 1,215,643.59 | 495,104.6 | 3,978,717.87 | 2,865,037.49 |
| 递延收益 | 218,511.37 | 218,511.37 | 218,511.37 | 219,911.37 |
| 递延所得税负债 | 5,280,360.86 | 5,780,948.17 | 4,155,412.6 | 3,934,796.97 |
| 非流动负债合计 | 122,164,168.4 | 132,137,306.02 | 137,657,022.3 | 141,353,423.12 |
| 负债合计 | 289,963,793.49 | 285,891,822.01 | 309,869,067.97 | 279,361,180.19 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 180,941,126 | 139,586,605 | 139,586,605 | 139,586,605 |
| 资本公积 | 730,663,162.71 | 774,983,792.4 | 772,927,119.67 | 771,013,817.28 |
| 减:库存股 | 45,091,392.43 | 53,080,912.43 | 53,080,912.43 | 53,080,912.43 |
| 其他综合收益 | -47,967.42 | -158,438.27 | -43,971.87 | -14,512.92 |
| 盈余公积 | 34,999,933.96 | 34,999,933.96 | 34,999,933.96 | 29,841,348.57 |
| 未分配利润 | 111,001,016.23 | 133,620,582.99 | 109,841,333.49 | 138,836,599.67 |
| 归属于母公司股东权益合计 | 1,012,465,879.05 | 1,029,951,563.65 | 1,004,230,107.82 | 1,026,182,945.17 |
| 股东权益合计 | 1,012,465,879.05 | 1,029,951,563.65 | 1,004,230,107.82 | 1,026,182,945.17 |
| 负债和股东权益合计 | 1,302,429,672.54 | 1,315,843,385.66 | 1,314,099,175.79 | 1,305,544,125.36 |
| 公告日期 | 2026-08-28 | 2026-04-29 | 2026-04-29 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |